Michael T Nurmohamed (M T Nurmohamed, Michael Nurmohamed, Mike T Nurmohamed, M Nurmohamed)

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 74

Top Topics

Rheumatoid Arthritis

Top Venues

Rheumatology international

Annals of the rheumatic diseases

Clinical rheumatology

This page only lists publications with an associated author ORCID identifier.

Publications

Violetta Dubovyk, Georgios K Vasileiadis, Tahzeeb Fatima, Yuan Zhang, Meliha Crnkic Kapetanovic, Alf Kastbom, Milad Rizk, Annika Söderbergh, Sizheng Steven Zhao, Ronald F Van Vollenhoven, Merete Lund Hetland, Espen A Haavardsholm, Dan Nordström, Michael T Nurmohamed, Bjorn Gudbjornsson, Jon Lampa, Mikkel Østergaard, Marte Schrumpf Heiberg, Tuulikki Sokka-Isler, Gerdur Gröndal, Kristina Lend, Kim Hørslev-Petersen, Till Uhlig, Anna Rudin, Cristina Maglio
Obesity is a risk factor for poor response to treatment in early rheumatoid arthritis: a NORD-STAR study. RMD open 10 (2) (2024)
Violetta Dubovyk, Georgios K Vasileiadis, Tahzeeb Fatima, Yuan Zhang, Meliha Crnkic Kapetanovic, Alf Kastbom, Milad Rizk, Annika Söderbergh, Sizheng Steven Zhao, Ronald F Van Vollenhoven, Merete Lund Hetland, Espen A Haavardsholm, Dan Nordström, Michael T Nurmohamed, Bjorn Gudbjornsson, Jon Lampa, Mikkel Østergaard, Marte Schrumpf Heiberg, Tuulikki Sokka-Isler, Gerdur Gröndal, Kristina Lend, Kim Hørslev-Petersen, Till Uhlig, Anna Rudin, Cristina Maglio
Obesity is a risk factor for poor response to treatment in early rheumatoid arthritis: a NORD-STAR study. RMD open 10 (2) (2024)
Violetta Dubovyk, Georgios K Vasileiadis, Tahzeeb Fatima, Yuan Zhang, Meliha Crnkic Kapetanovic, Alf Kastbom, Milad Rizk, Annika Söderbergh, Sizheng Steven Zhao, Ronald F Van Vollenhoven, Merete Lund Hetland, Espen A Haavardsholm, Dan Nordström, Michael T Nurmohamed, Bjorn Gudbjornsson, Jon Lampa, Mikkel Østergaard, Marte Schrumpf Heiberg, Tuulikki Sokka-Isler, Gerdur Gröndal, Kristina Lend, Kim Hørslev-Petersen, Till Uhlig, Anna Rudin, Cristina Maglio
Obesity is a risk factor for poor response to treatment in early rheumatoid arthritis: a NORD-STAR study. RMD open 10 (2) (2024)
Yaëlle R Besten, Laura Boekel, Maurice Steenhuis, Femke Hooijberg, Sadaf Atiqi, Maureen Leeuw, Erik H Vogelzang, Jim Keijser, Sofie Keijzer, Floris C Loeff, Martijn Gerritsen, Sander W Tas, Michael T Nurmohamed, Theo Rispens, Gertjan Wolbink
Patient-perspective and feasibility of home finger-prick testing to complement and facilitate large-scale research in rheumatology. RMD open 10 (2) (2024)
Yaëlle R Besten, Laura Boekel, Maurice Steenhuis, Femke Hooijberg, Sadaf Atiqi, Maureen Leeuw, Erik H Vogelzang, Jim Keijser, Sofie Keijzer, Floris C Loeff, Martijn Gerritsen, Sander W Tas, Michael T Nurmohamed, Theo Rispens, Gertjan Wolbink
Patient-perspective and feasibility of home finger-prick testing to complement and facilitate large-scale research in rheumatology. RMD open 10 (2) (2024)
Martijn Gerritsen, Michael T Nurmohamed
The Effects of Pharmacological Urate-Lowering Therapy on Cardiovascular Disease in Older Adults with Gout. Drugs & aging (2024)
Martijn Gerritsen, Michael T Nurmohamed
The Effects of Pharmacological Urate-Lowering Therapy on Cardiovascular Disease in Older Adults with Gout. Drugs & aging 41 (4) (2024)
Yaëlle R Besten, Laura Boekel, Maurice Steenhuis, Femke Hooijberg, Sadaf Atiqi, Maureen Leeuw, Erik H Vogelzang, Jim Keijser, Sofie Keijzer, Floris C Loeff, Martijn Gerritsen, Sander W Tas, Michael T Nurmohamed, Theo Rispens, Gertjan Wolbink
Patient-perspective and feasibility of home finger-prick testing to complement and facilitate large-scale research in rheumatology. RMD open 10 (2) (2024)
Yaëlle R Besten, Laura Boekel, Maurice Steenhuis, Femke Hooijberg, Sadaf Atiqi, Maureen Leeuw, Erik H Vogelzang, Jim Keijser, Sofie Keijzer, Floris C Loeff, Martijn Gerritsen, Sander W Tas, Michael T Nurmohamed, Theo Rispens, Gertjan Wolbink
Patient-perspective and feasibility of home finger-prick testing to complement and facilitate large-scale research in rheumatology. RMD open 10 (2) (2024)
Violetta Dubovyk, Georgios K Vasileiadis, Tahzeeb Fatima, Yuan Zhang, Meliha Crnkic Kapetanovic, Alf Kastbom, Milad Rizk, Annika Söderbergh, Sizheng Steven Zhao, Ronald F Van Vollenhoven, Merete Lund Hetland, Espen A Haavardsholm, Dan Nordström, Michael T Nurmohamed, Bjorn Gudbjornsson, Jon Lampa, Mikkel Østergaard, Marte Schrumpf Heiberg, Tuulikki Sokka-Isler, Gerdur Gröndal, Kristina Lend, Kim Hørslev-Petersen, Till Uhlig, Anna Rudin, Cristina Maglio
Obesity is a risk factor for poor response to treatment in early rheumatoid arthritis: a NORD-STAR study. RMD open 10 (2) (2024)
Kristina Lend, Jon Lampa, Leonid Padyukov, Merete Lund Hetland, Marte Schrumpf Heiberg, Dan C Nordström, Michael T Nurmohamed, Anna Rudin, Mikkel Østergaard, Espen A Haavardsholm, Kim Hørslev-Petersen, Till Uhlig, Tuulikki Sokka, Bjorn Gudbjornsson, Gerdur Grondal, Giulia Frazzei, Jeroen Christiaans, Gerrit J Wolbink, Theo Rispens, Jos W R Twisk, Ronald F Van Vollenhoven
Association of rheumatoid factor, anti-citrullinated protein antibodies and shared epitope with clinical response to initial treatment in patients with early rheumatoid arthritis: data from a randomised controlled trial. Annals of the rheumatic diseases (2024)
Martijn Gerritsen, Michael T Nurmohamed
The Effects of Pharmacological Urate-Lowering Therapy on Cardiovascular Disease in Older Adults with Gout. Drugs & aging 41 (4) (2024)
Yaëlle R Besten, Laura Boekel, Maurice Steenhuis, Femke Hooijberg, Sadaf Atiqi, Maureen Leeuw, Erik H Vogelzang, Jim Keijser, Sofie Keijzer, Floris C Loeff, Martijn Gerritsen, Sander W Tas, Michael T Nurmohamed, Theo Rispens, Gertjan Wolbink
Patient-perspective and feasibility of home finger-prick testing to complement and facilitate large-scale research in rheumatology. RMD open 10 (2) (2024)
Pasoon Hellamand, Marleen G H van de Sande, Michael T Nurmohamed, Ronald F Van Vollenhoven, Rosemary J Hollick, Ovidiu Rotariu, Žiga Rotar, Katja Perdan Pirkmajer, Dan Nordström, Anna-Mari Hokkanen, Brigitte Michelsen, Tore K Kvien, Bente Glintborg, Merete Lund Hetland, Mikkel Østergaard, Anne Gitte Loft, Karel Pavelka, Jakub Závada, Isabel Castrejon, Lucia Otero Varela, Bjorn Gudbjornsson, Olafur Palsson, Tor Olofsson, Johan Karlsson Wallman, Adrian Ciurea, Michael John Nissen, Tuba D Yildirim, Fatoş Önen, Catalin Codreanu, Corina Mogosan, Maria Jose Santos, Elsa Viera Sousa, Florenzo Iannone, Bruno Frediani, Lykke Midtbøll Ørnbjerg, Jos W R Twisk, Irene E van der Horst-Bruinsma
Sex differences in patient-reported outcomes and the association with clinical factors in axial spondyloarthritis patients treated with tumour necrosis factor inhibitors. Rheumatology (Oxford, England) (2024)
Violetta Dubovyk, Georgios K Vasileiadis, Tahzeeb Fatima, Yuan Zhang, Meliha Crnkic Kapetanovic, Alf Kastbom, Milad Rizk, Annika Söderbergh, Sizheng Steven Zhao, Ronald F Van Vollenhoven, Merete Lund Hetland, Espen A Haavardsholm, Dan Nordström, Michael T Nurmohamed, Bjorn Gudbjornsson, Jon Lampa, Mikkel Østergaard, Marte Schrumpf Heiberg, Tuulikki Sokka-Isler, Gerdur Gröndal, Kristina Lend, Kim Hørslev-Petersen, Till Uhlig, Anna Rudin, Cristina Maglio
Obesity is a risk factor for poor response to treatment in early rheumatoid arthritis: a NORD-STAR study. RMD open 10 (2) (2024)
Bafrin Abdulmajid, Annelies B Blanken, Eva H van Geel, Joost G Daams, Michael T Nurmohamed
Effect of TNF inhibitors on arterial stiffness and intima media thickness in rheumatoid arthritis: a systematic review and meta-analysis. Clinical rheumatology 42 (4) (2023)
Bafrin Abdulmajid, Annelies B Blanken, Eva H van Geel, Joost G Daams, Michael T Nurmohamed
Effect of TNF inhibitors on arterial stiffness and intima media thickness in rheumatoid arthritis: a systematic review and meta-analysis. Clinical rheumatology 42 (4) (2023)
Bart F Seppen, Jimmy Wiegel, Michael T Nurmohamed, Wouter H Bos, Marieke M Ter Wee
Facilitators and barriers to adhere to monitoring disease activity with ePROs: a focus group study in patients with inflammatory arthritis. Rheumatology international 43 (4) (2023)
J van den Hoek, M Sobejana, Fenna van Nes, Georgios S Metsios, George D Kitas, Marike van der Leeden, Michael T Nurmohamed, Martin van der Esch
Patient perspective on exercise intervention in rheumatoid arthritis with high risk of cardiovascular disease: a pilot qualitative study. Rheumatology international 43 (7) (2023)
Bart F Seppen, Jimmy Wiegel, Michael T Nurmohamed, Wouter H Bos, Marieke M Ter Wee
Facilitators and barriers to adhere to monitoring disease activity with ePROs: a focus group study in patients with inflammatory arthritis. Rheumatology international (2023)
Bart F Seppen, Jimmy Wiegel, Michael T Nurmohamed, Wouter H Bos, Marieke M Ter Wee
Facilitators and barriers to adhere to monitoring disease activity with ePROs: a focus group study in patients with inflammatory arthritis. Rheumatology international 43 (4) (2023)
Annelies B Blanken, M Korteweg, Laurette van Boheemen, Ronald F Van Vollenhoven, Michael T Nurmohamed, Conny J van der Laken
Clinical evaluation of optical spectral transmission imaging for detection of disease activity in rheumatoid arthritis. Scandinavian journal of rheumatology (2023)
Jimmy Wiegel, Bart F Seppen, Michael T Nurmohamed, Marieke M Ter Wee, Wouter H Bos
Predictors for response to electronic patient-reported outcomes in routine care in patients with rheumatoid arthritis: a retrospective cohort study. Rheumatology international 43 (4) (2023)
Helen R Gosselt, Jette A van Lint, Leanne J Kosse, Phyllis I Spuls, Harald E Vonkeman, Sander W Tas, Frank Hoentjen, Michael T Nurmohamed, Bart J F van den Bemt, Martijn Bastiaan Adriaan van Doorn, Naomi T Jessurun
Sex differences in adverse drug reactions from adalimumab and etanercept in patients with inflammatory rheumatic diseases. Expert opinion on drug safety (2023)
Bafrin Abdulmajid, Annelies B Blanken, Eva H van Geel, Joost G Daams, Michael T Nurmohamed
Effect of TNF inhibitors on arterial stiffness and intima media thickness in rheumatoid arthritis: a systematic review and meta-analysis. Clinical rheumatology (2023)
Kristina Lend, Frieda A Koopman, Jon Lampa, Gerrit Jansen, Merete Hetland L, Till Uhlig, Dan Nordström, Michael T Nurmohamed, Bjorn Gudbjornsson, Anna Rudin, Mikkel Østergaard, Marte S Heiberg, Tuulikki Sokka-Isler, Kim Hørslev-Petersen, Espen A Haavardsholm, Gerdur Grondal, Jos W R Twisk, Ronald van Vollenhoven
Methotrexate safety and efficacy in combination therapies in patients with early rheumatoid arthritis: a post-hoc analysis of a randomized controlled trial (NORD-STAR). Arthritis & rheumatology (Hoboken, N.J.) (2023)
Bart F Seppen, Jimmy Wiegel, Michael T Nurmohamed, Wouter H Bos, Marieke M Ter Wee
Facilitators and barriers to adhere to monitoring disease activity with ePROs: a focus group study in patients with inflammatory arthritis. Rheumatology international 43 (4) (2023)
Mikkel Østergaard, Ronald F Van Vollenhoven, Anna Rudin, Merete Lund Hetland, Marte Schrumpf Heiberg, Dan C Nordström, Michael T Nurmohamed, Bjorn Gudbjornsson, Lykke Midtbøll Ørnbjerg, Pernille Bøyesen, Kristina Lend, Kim Hørslev-Petersen, Till Uhlig, Tuulikki Sokka, Gerdur Grondal, Simon Krabbe, Joakim Lindqvist, Inger Gjertsson, Daniel Glinatsi, Meliha Crnkic Kapetanovic, Anna-Birgitte Aga, Francesca Faustini, Pinja Parmanne, Tove Lorenzen, Cagnotto Giovanni, Johan Back, Oliver Hendricks, Daisy Vedder, Tuomas Rannio, Emma Grenholm, Maud Kristine Ljoså, Eli Brodin, Hanne Lindegaard, Annika Söderbergh, Milad Rizk, Alf Kastbom, Per Larsson, Line Uhrenholt, Søren Andreas Just, David J Stevens, Trine Bay Laurbjerg, Gunnstein Bakland, Inge Christoffer Olsen, Espen A Haavardsholm, Jon Lampa, null null
Certolizumab pegol, abatacept, tocilizumab or active conventional treatment in early rheumatoid arthritis: 48-week clinical and radiographic results of the investigator-initiated randomised controlled NORD-STAR trial. Annals of the rheumatic diseases (2023)
Bart F Seppen, Jimmy Wiegel, Michael T Nurmohamed, Wouter H Bos, Marieke M Ter Wee
Facilitators and barriers to adhere to monitoring disease activity with ePROs: a focus group study in patients with inflammatory arthritis. Rheumatology international 43 (4) (2023)
J van den Hoek, M Sobejana, Fenna van Nes, Georgios S Metsios, George D Kitas, Marike van der Leeden, Michael T Nurmohamed, Martin van der Esch
Patient perspective on exercise intervention in rheumatoid arthritis with high risk of cardiovascular disease: a pilot qualitative study. Rheumatology international (2023)
Reinder Raadsen, Romy Hansildaar, Lianne C Pouw, Femke Hooijberg, Laura Boekel, Gerrit Jan Wolbink, Arno W R van Kuijk, Michael T Nurmohamed
Cardiovascular disease risk in patients with inflammatory arthritis nowadays still substantially elevated. RMD open 9 (4) (2023)
Bafrin Abdulmajid, Annelies B Blanken, Eva H van Geel, Joost G Daams, Michael T Nurmohamed
Effect of TNF inhibitors on arterial stiffness and intima media thickness in rheumatoid arthritis: a systematic review and meta-analysis. Clinical rheumatology 42 (4) (2023)
M Sobejana, Willem F Lems, J van den Hoek, George D Kitas, Marike van der Leeden, Michael T Nurmohamed, Georgios S Metsios
Do Disease-Modifying Anti-rheumatic Drugs and Exercise Therapy Have a Combined Effect on Disease Activity in Patients with RA? A Scoping Review. Current rheumatology reports (2023)
J van den Hoek, M Sobejana, Fenna van Nes, Georgios S Metsios, George D Kitas, Marike van der Leeden, Michael T Nurmohamed, Martin van der Esch
Patient perspective on exercise intervention in rheumatoid arthritis with high risk of cardiovascular disease: a pilot qualitative study. Rheumatology international 43 (7) (2023)
Jimmy Wiegel, Bart F Seppen, Michael T Nurmohamed, Marieke M Ter Wee, Wouter H Bos
Predictors for response to electronic patient-reported outcomes in routine care in patients with rheumatoid arthritis: a retrospective cohort study. Rheumatology international (2023)
Jimmy Wiegel, Bart F Seppen, Michael T Nurmohamed, Marieke M Ter Wee, Wouter H Bos
Predictors for response to electronic patient-reported outcomes in routine care in patients with rheumatoid arthritis: a retrospective cohort study. Rheumatology international 43 (4) (2023)
Bafrin Abdulmajid, Annelies B Blanken, Eva H van Geel, Joost G Daams, Michael T Nurmohamed
Effect of TNF inhibitors on arterial stiffness and intima media thickness in rheumatoid arthritis: a systematic review and meta-analysis. Clinical rheumatology 42 (4) (2023)
J van den Hoek, M Sobejana, Fenna van Nes, Georgios S Metsios, George D Kitas, Marike van der Leeden, Michael T Nurmohamed, Martin van der Esch
Patient perspective on exercise intervention in rheumatoid arthritis with high risk of cardiovascular disease: a pilot qualitative study. Rheumatology international (2023)
Jimmy Wiegel, Bart F Seppen, Michael T Nurmohamed, Marieke M Ter Wee, Wouter H Bos
Predictors for response to electronic patient-reported outcomes in routine care in patients with rheumatoid arthritis: a retrospective cohort study. Rheumatology international (2023)
Helen R Gosselt, Jette A van Lint, Leanne J Kosse, Phyllis I Spuls, Harald E Vonkeman, Sander W Tas, Frank Hoentjen, Michael T Nurmohamed, Bart J F van den Bemt, Martijn Bastiaan Adriaan van Doorn, Naomi T Jessurun
Sex differences in adverse drug reactions from Adalimumab and etanercept in patients with inflammatory rheumatic diseases. Expert opinion on drug safety (2023)
Jimmy Wiegel, Bart F Seppen, Michael T Nurmohamed, Marieke M Ter Wee, Wouter H Bos
Predictors for response to electronic patient-reported outcomes in routine care in patients with rheumatoid arthritis: a retrospective cohort study. Rheumatology international 43 (4) (2023)
J van den Hoek, M Sobejana, Fenna van Nes, Georgios S Metsios, George D Kitas, Marike van der Leeden, Michael T Nurmohamed, Martin van der Esch
Patient perspective on exercise intervention in rheumatoid arthritis with high risk of cardiovascular disease: a pilot qualitative study. Rheumatology international 43 (7) (2023)
J van den Hoek, M Sobejana, Fenna van Nes, Georgios S Metsios, George D Kitas, Marike van der Leeden, Michael T Nurmohamed, Martin van der Esch
Patient perspective on exercise intervention in rheumatoid arthritis with high risk of cardiovascular disease: a pilot qualitative study. Rheumatology international (2023)
Laura Boekel, Femke Hooijberg, Erik H Vogelzang, Yaëlle R Besten, Maureen Leeuw, Sadaf Atiqi, Ronald F Van Vollenhoven, Carla A Wijbrandts, Martijn Gerritsen, Charlotte Lm Krieckaert, Bas Dijkshoorn, Siham Bakhlakh, Juliette J Crooijmans, Alexandre Voskuyl, Irene E van der Horst-Bruinsma, Willem F Lems, Taco W Kuijpers, S Marieke van Ham, Luuk Wieske, Filip Eftimov, Laura Y Kummer, Pj Koos van Dam, Eileen W Stalman, Maurice Steenhuis, Sofie Keijzer, Olvi Cristianawati, Jim Keijser, Floris C Loeff, Sander W Tas, Michael T Nurmohamed, Maarten Boers, Theo Rispens, Gertjan Wolbink
Antibody development and disease severity of COVID-19 in non-immunised patients with rheumatic immune-mediated inflammatory diseases: data from a prospective cohort study. RMD open 8 (1) (2022)
Ingrid M Visman, Maarten Boers, Daisy Vedder, Jos Wr Twisk, Michael T Nurmohamed
Routine treatment of rheumatoid arthritis with biologics and targeted agents: changes in patients and their response over 15 years. Annals of the rheumatic diseases (2022)
Maria Konsta, Michael T Nurmohamed, Alexios Iliopoulos, Petros P Sfikakis, J Christiaan van Denderen, Ingrid M Visman, Grigorios T Sakelariou, Irene E van der Horst-Bruinsma
Prevalence and Radiographic Progression of Hip Involvement in Patients With Ankylosing Spondylitis Treated With Tumor Necrosis Factor Inhibitors. The Journal of rheumatology (2022)
M Sobejana, J van den Hoek, Georgios S Metsios, George D Kitas, Marike van der Leeden, S Verberne, Harald T Jørstad, Mirjam Pijnappels, Willem F Lems, Michael T Nurmohamed, M van der Esch
Exercise intervention on cardiorespiratory fitness in rheumatoid arthritis patients with high cardiovascular disease risk: a single-arm pilot study. Clinical rheumatology 41 (12) (2022)
Henrike J Westerink, Leanne J Kosse, Naomi T Jessurun, Astrid van Tubergen, Harald E Vonkeman, Michael T Nurmohamed, Bart J F van den Bemt, Marieke de Vries
Patients' and health-care professionals' perspectives on adverse drug reaction burden attributed to the use of biological DMARDs: a qualitative study. Expert opinion on drug safety (2022)
Lieke H Roest, Leanne J Kosse, Jette A van Lint, Helen R Gosselt, Joep H G Scholl, Eugene P van Puijenbroek, Harald E Vonkeman, Sander W Tas, Michael T Nurmohamed, Bart J F van den Bemt, Naomi T Jessurun
Disease-specific ADRs of TNF-α inhibitors as reported by patients with inflammatory rheumatic diseases: a registry-based prospective multicenter cohort study. Expert opinion on drug safety (2022)
Merel de Boer, Helen R Gosselt, Jurriaan Jansen, Martijn Bastiaan Adriaan van Doorn, Frank Hoentjen, Michael T Nurmohamed, Phyllis I Spuls, Sander W Tas, Harald E Vonkeman, Naomi T Jessurun
Analysis and visualization of the course and burden over time of adverse drug reactions (ADRs) attributed to TNFα-inhibitors in patients with inflammatory rheumatic diseases (IRDs). Expert opinion on drug safety (2022)
Daniel Aletaha, Andreas Kerschbaumer, Kastriot Kastrati, Christian Dejaco, Maxime Dougados, Iain B McInnes, Naveed Sattar, Tanja Alexandra Stamm, Tsutomu Takeuchi, Michael Trauner, Désirée Mfm van der Heijde, Marieke Voshaar, Kevin L Winthrop, Angelo Ravelli, Neil Betteridge, Gerd-Rüdiger R Burmester, Johannes W J Bijlsma, Vivian Bykerk, Roberto Caporali, Ernest H S Choy, Catalin Codreanu, Bernard Combe, Mary K Crow, Maarten P T de Wit, Paul Emery, Roy M Fleischmann, Cem Gabay, Merete Lund Hetland, Kimmie L Hyrich, AnnaMaria Iagnocco, John Dudley Isaacs, Joel M Kremer, Xavier Mariette, Peter A Merkel, Eduardo F Mysler, Peter Nash, Michael T Nurmohamed, Karel Pavelka, Gyula Poor, Andrea Rubbert-Roth, Hendrik Schulze-Koops, Anja Strangfeld, Yoshiya Tanaka, Josef S Smolen
Consensus statement on blocking interleukin-6 receptor and interleukin-6 in inflammatory conditions: an update. Annals of the rheumatic diseases (2022)
Laure Gossec, Stefan Siebert, Paul Bergmans, Kurt de Vlam, Elisa Gremese, Beatríz Joven-Ibáñez, Tatiana V Korotaeva, Frederic Lavie, Wim Noël, Michael T Nurmohamed, Petros P Sfikakis, Elke Theander, Josef S Smolen
Persistence and effectiveness of the IL-12/23 pathway inhibitor ustekinumab or tumour necrosis factor inhibitor treatment in patients with psoriatic arthritis: 1-year results from the real-world PsABio Study. Annals of the rheumatic diseases 81 (6) (2022)
Laure Gossec, Stefan Siebert, Paul Bergmans, Kurt de Vlam, Elisa Gremese, Beatriz Joven-Ibáñez, Tatiana V Korotaeva, Frederic Lavie, Wim Noël, Michael T Nurmohamed, Petros P Sfikakis, Mohamed Sharaf, Elke Theander, Josef S Smolen
Long-term effectiveness and persistence of ustekinumab and TNF inhibitors in patients with psoriatic arthritis: final 3-year results from the PsABio real-world study. Annals of the rheumatic diseases (2022)
J Ruwaard, M J L' Ami, E L Kneepkens, Clm Krieckaert, Michael T Nurmohamed, F Hooijberg, Awr van Kuijk, J C van Denderen, L Burgemeister, Theo Rispens, M Boers, Gerrit J Wolbink
Interval prolongation of etanercept in rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis: a randomized controlled trial. Scandinavian journal of rheumatology (2022)
Laure Gossec, Stefan Siebert, Paul Bergmans, Kurt de Vlam, Elisa Gremese, Beatriz Joven-Ibáñez, Tatiana V Korotaeva, Frederic Lavie, Wim Noël, Michael T Nurmohamed, Petros P Sfikakis, Mohamed Sharaf, Elke Theander, Josef S Smolen
Long-term effectiveness and persistence of ustekinumab and TNF inhibitors in patients with psoriatic arthritis: final 3-year results from the PsABio real-world study. Annals of the rheumatic diseases (2022)
Laure Gossec, Stefan Siebert, Paul Bergmans, Kurt de Vlam, Elisa Gremese, Beatriz Joven-Ibáñez, Tatiana V Korotaeva, Frederic Lavie, Wim Noël, Michael T Nurmohamed, Petros P Sfikakis, Mohamed Sharaf, Elke Theander, Josef S Smolen
Long-term effectiveness and persistence of ustekinumab and TNF inhibitors in patients with psoriatic arthritis: final 3-year results from the PsABio real-world study. Annals of the rheumatic diseases (2022)
Tamara Rusman, Mac van der Weijden, Michael T Nurmohamed, C J van Denderen, Robert B M Landewe, Pierre M Bet, Cma van der Bijl, Conny J van der Laken, Irene E van der Horst-Bruinsma
Does a short course of etanercept influence disease progression and radiographic changes in patients suspected of non-radiographic axial spondyloarthritis? Three -years follow- up of a placebo-controlled trial. Scandinavian journal of rheumatology (2022)
S C Heslinga, Charlotte E Teunissen, Rabia Agca, Diane van der Woude, Thomas Wj Huizinga, Jacob M van Laar, Alfons A den Broeder, Willem F Lems, Michael T Nurmohamed
NT-proBNP and sRAGE levels in early rheumatoid arthritis. Scandinavian journal of rheumatology (2022)
Bas Dijkshoorn, Reinder Raadsen, Michael T Nurmohamed
Cardiovascular Disease Risk in Rheumatoid Arthritis Anno 2022. Journal of clinical medicine 11 (10) (2022)
Renske C F Hebing, Marry Lin, Maja Bulatovic Calasan, Ittai B Muller, Sohaila Mahmoud, Sandra Heil, Eduard A Struys, Bart Jf van den Bemt, Jos Wr Twisk, Willem F Lems, Michael T Nurmohamed, Gerrit Jansen, Robert de Jonge
Pharmacokinetics of oral and subcutaneous methotrexate in red and white blood cells in patients with early rheumatoid arthritis: the methotrexate monitoring trial. Annals of the rheumatic diseases (2022)
Laure Gossec, Stefan Siebert, Paul Bergmans, Kurt de Vlam, Elisa Gremese, Beatriz Joven-Ibáñez, Tatiana V Korotaeva, Frederic Lavie, Wim Noël, Michael T Nurmohamed, Petros P Sfikakis, Mohamed Sharaf, Elke Theander, Josef S Smolen
Long-term effectiveness and persistence of ustekinumab and TNF inhibitors in patients with psoriatic arthritis: final 3-year results from the PsABio real-world study. Annals of the rheumatic diseases (2022)
Laure Gossec, Stefan Siebert, Paul Bergmans, Kurt de Vlam, Elisa Gremese, Beatriz Joven-Ibáñez, Tatiana V Korotaeva, Frederic Lavie, Wim Noël, Michael T Nurmohamed, Petros P Sfikakis, Mohamed Sharaf, Elke Theander, Josef S Smolen
Long-term effectiveness and persistence of ustekinumab and TNF inhibitors in patients with psoriatic arthritis: final 3-year results from the PsABio real-world study. Annals of the rheumatic diseases (2022)
Renske C F Hebing, Iremnur Aksu, Jos Wr Twisk, Wouter Bos, Bart Van den Bemt, Michael T Nurmohamed
Effectiveness of electronic drug monitoring feedback to increase adherence in patients with RA initiating a biological DMARD: a randomised clinical trial. RMD open 8 (1) (2022)
Leanne J Kosse, Gerda Weits, Harald E Vonkeman, Sander W Tas, Frank Hoentjen, Martijn Bastiaan Adriaan van Doorn, Phyllis I Spuls, Geert R A M D'Haens, Michael T Nurmohamed, Eugene P van Puijenbroek, Bart Jf Van Den Bemt, Naomi T Jessurun
Patients' perspectives on a drug safety monitoring system for immune-mediated inflammatory diseases based on patient-reported outcomes. Expert opinion on drug safety 20 (12) (2021)
Laurette van Boheemen, Samina Turk, Marian van Beers-Tas, Wouter Bos, Diane Marsman, Ed N Griep, Mirian Starmans-Kool, Calin D Popa, Alper van Sijl, Maarten Boers, Michael T Nurmohamed, Dirkjan van Schaardenburg
Atorvastatin is unlikely to prevent rheumatoid arthritis in high risk individuals: results from the prematurely stopped STAtins to Prevent Rheumatoid Arthritis (STAPRA) trial. RMD open 7 (1) (2021)
Jette A van Lint, Florence P A M van Hunsel, Sander W Tas, Harald E Vonkeman, Frank Hoentjen, Martijn Bastiaan Adriaan van Doorn, Renske C F Hebing, Michael T Nurmohamed, Bart J F van den Bemt, Eugene P van Puijenbroek, Naomi T Jessurun
Hypoglycaemia following JAK inhibitor treatment in patients with diabetes. Annals of the rheumatic diseases 81 (4) (2021)
M Sobejana, J van den Hoek, Georgios S Metsios, George D Kitas, Harald T Jørstad, Marike van der Leeden, Mirjam Pijnappels, Willem F Lems, Michael T Nurmohamed, Martin van der Esch
Cardiorespiratory fitness and physical activity in people who have rheumatoid arthritis at an increased risk of cardiovascular disease: a cross-sectional study. Rheumatology international 41 (12) (2021)
Ronald F Van Vollenhoven, Sander W Tas, Michael T Nurmohamed
Correspondence on "Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: results from the COVID-19 global rheumatology alliance physician registry" by Sparks et al. Annals of the rheumatic diseases (2021)
M J J Lucassen, Marieke M Ter Wee, D den Uyl, N P C Konijn, Michael T Nurmohamed, Alexandre E Voskuyl, Dirkjan van Schaardenburg, P J S M Kerstens, Irene E M Bultink, Maarten Boers, Willem F Lems
Long-term effects on bone mineral density after four years of treatment with two intensive combination strategies, including initially high-dose prednisolone, in early rheumatoid arthritis patients: the COBRA-light trial. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 32 (7) (2021)
Lea C Berkhout, Merel J l'Ami, Jill Ruwaard, Margreet H Hart, Pleuni Ooijevaar-de Heer, Karien Bloem, Michael T Nurmohamed, Ronald F van Vollenhoven, Maarten Boers, Daniel F Alvarez, Catherine H Smith, Gerrit J Wolbink, Theo Rispens
Dynamics of circulating TNF during adalimumab treatment using a drug-tolerant TNF assay. Science translational medicine 11 (477) (2020)
I A M van den Oever, M Baniaamam, S Simsek, Hennie G Raterman, J C van Denderen, I C van Eijk, M J L Peters, I E van der Horst-Bruinsma, Yvo Michiel Smulders, Michael T Nurmohamed
The effect of anti-TNF treatment on body composition and insulin resistance in patients with rheumatoid arthritis. Rheumatology international 41 (2) (2020)
Bart F Seppen, Merel J l'Ami, Sharon Duarte Dos Santos Rico, Marieke M Ter Wee, Franktien Turkstra, Leo D Roorda, Fabio S Catarinella, Dirkjan van Schaardenburg, Michael T Nurmohamed, Maarten Boers, Wouter H Bos
A Smartphone App for Self-Monitoring of Rheumatoid Arthritis Disease Activity to Assist Patient-Initiated Care: Protocol for a Randomized Controlled Trial. JMIR research protocols 9 (2) (2020)
Tamara Rusman, Marie-Luise B John, Mignon A C van der Weijden, Bouke J H Boden, Carmella M A van der Bijl, Stefan T G Bruijnen, Conny J van der Laken, Michael T Nurmohamed, Irene E van der Horst-Bruinsma
Presence of active MRI lesions in patients suspected of non-radiographic axial spondyloarthritis with high disease activity and chance at conversion after a 6-month follow-up period. Clinical rheumatology 39 (5) (2020)
Rabia Agca, Sjoerd C Heslinga, S Rollefstad, S Heslinga, Anna Södergren, A G Semb, George D Kitas, Naveed Sattar, Michael T Nurmohamed, null null
Response to: "Influence of changes in cholesterol levels and disease activity on the 10-year cardiovascular risk estimated with different algorithms in rheumatoid arthritis patients" by Fornaro et al. Annals of the rheumatic diseases 79 (9) (2019)